僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Pozelimab （REGN3918） is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases